JP2015107924A5 - - Google Patents

Download PDF

Info

Publication number
JP2015107924A5
JP2015107924A5 JP2013250977A JP2013250977A JP2015107924A5 JP 2015107924 A5 JP2015107924 A5 JP 2015107924A5 JP 2013250977 A JP2013250977 A JP 2013250977A JP 2013250977 A JP2013250977 A JP 2013250977A JP 2015107924 A5 JP2015107924 A5 JP 2015107924A5
Authority
JP
Japan
Prior art keywords
preventing
extract
improving
asparathus
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013250977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015107924A (ja
JP6236304B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013250977A priority Critical patent/JP6236304B2/ja
Priority claimed from JP2013250977A external-priority patent/JP6236304B2/ja
Publication of JP2015107924A publication Critical patent/JP2015107924A/ja
Publication of JP2015107924A5 publication Critical patent/JP2015107924A5/ja
Application granted granted Critical
Publication of JP6236304B2 publication Critical patent/JP6236304B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013250977A 2013-12-04 2013-12-04 涙液分泌促進剤 Active JP6236304B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013250977A JP6236304B2 (ja) 2013-12-04 2013-12-04 涙液分泌促進剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013250977A JP6236304B2 (ja) 2013-12-04 2013-12-04 涙液分泌促進剤

Publications (3)

Publication Number Publication Date
JP2015107924A JP2015107924A (ja) 2015-06-11
JP2015107924A5 true JP2015107924A5 (enExample) 2017-01-12
JP6236304B2 JP6236304B2 (ja) 2017-11-22

Family

ID=53438606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013250977A Active JP6236304B2 (ja) 2013-12-04 2013-12-04 涙液分泌促進剤

Country Status (1)

Country Link
JP (1) JP6236304B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210003716A (ko) * 2018-04-26 2021-01-12 라이온 가부시키가이샤 외분비 촉진제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2895298B2 (ja) * 1991-12-27 1999-05-24 株式会社ユニエ 活性酸素消去・除去剤
JPH05271058A (ja) * 1992-03-06 1993-10-19 Ruibosuteii Japan:Kk 白内障改善治療剤
JPH07196523A (ja) * 1994-01-07 1995-08-01 Oomiya Yakugyo Kk ケルセチン配糖体を含有する内用液剤
JPH08133983A (ja) * 1994-11-02 1996-05-28 Asugen Seiyaku Kk アスパラス・リネアリス抽出物及び用途
JP2006298876A (ja) * 2005-04-25 2006-11-02 Saisentan Igaku Kenkyusho:Kk サーチュインの活性化剤を含む各種眼疾患治療用組成物
JPWO2005085223A1 (ja) * 2004-03-04 2007-12-13 和夫 永井 骨疾患の予防及び／又は治療用組成物、その組成物を含有する機能性食品もしくは健康食品、並びにその組成物を有効成分とする医薬製剤
US20070212395A1 (en) * 2006-03-08 2007-09-13 Allergan, Inc. Ocular therapy using sirtuin-activating agents
JP2008110962A (ja) * 2006-08-02 2008-05-15 Santen Pharmaceut Co Ltd Ｎｒｆ２活性化物質を有効成分として含む角結膜障害の予防または治療剤
EP2161026B1 (de) * 2008-09-05 2012-12-26 Kneipp-Werke Kneipp-Mittel-Zentrale GmbH & Co. KG Kombination von Extrakten aus verschiedenen Pflanzen zur Verbesserung der Symptome von Demenzerkrankungen
EP2496233A1 (en) * 2009-11-06 2012-09-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye
AU2010330813B2 (en) * 2009-12-18 2016-04-28 Exodos Life Sciences Limited Partnership Methods and compositions for treating peripheral vascular disease

Similar Documents

Publication Publication Date Title
CA2956871C (en) Compounds active towards bromodomains
WO2017100063A3 (en) Stable ready-to-drink beverage compositions comprising lipophilic active agents
WO2016064082A3 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
WO2016004068A8 (en) Hydrogel compositions comprising encapsulated cells and methods of use thereof
IL236123A0 (en) Preparations containing n-[4,2-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-4,1-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cftr-mediated disorders
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
WO2013103919A8 (en) Compositions and methods for treating metabolic disorders
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
WO2012106393A3 (en) Withanolide isolated from physalis longifolia and analogs and methods of use thereof
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
PL3232780T3 (pl) Kompozycje adiuwantowe zawierające wodny elektrolit, kompozycje zawierające składnik czynny i ich zastosowanie
WO2015120372A3 (en) Compositions and methods to inhibit ezh2 for the treatment of cardiovascular diseases
EP3255140C0 (en) LACTIC ACID BACTERIA, NATURAL IMMUNOACTIVATOR AND INFECTION PREVENTIVE/THERAPEUTIC AGENT DERIVED FROM SAID LACTIC ACID BACTERIA AND FOOD/DRINK
JP2015116187A5 (enExample)
MY169169A (en) Green tea beverage
SG11201502096VA (en) NOVEL EXTRACTS OF CYNARA SCOLYMUS, COFFEA spp. AND OLEA EUROPAEA FOR THE TREATMENT OF METABOLIC SYNDROME
EP2575842A4 (en) COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
HK1225994A1 (zh) 用於治疗过敏性病症的组合物
JP2015107925A5 (enExample)
PL3019182T3 (pl) Kompozycja zawierająca oczyszczony wyciąg wyodrębniony z pseudolysimachion rotundum var. subintegrum zawierający dużą ilość składnika czynnego lub związki z niego wyodrębnione jako składnik czynny do zapobiegania lub leczenia przewlekłej obturacyjnej choroby płuc oraz jej zastosowania
WO2014116015A3 (ko) 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
JP2015107924A5 (enExample)